Prospective Study of the Use of a Mesh to Prevent Parastomal Hernia After Laparoscopic Abdominoperineal Resection
NCT ID: NCT01722565
Last Updated: 2015-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
32 participants
INTERVENTIONAL
2012-01-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: to evaluate the effectiveness of the insertion of a prosthesis to prevent PH in elective surgery for laparoscopic abdominoperineal resection.
Methodology: prospective, multidisciplinary, multi-center randomized controlled study. Control group: Rectal neoplasms undergoing elective surgery for laparoscopic abdominoperineal resection. Study group: Rectal neoplasms undergoing elective surgery for laparoscopic abdominoperineal resection with a lightweight mesh (polypropylene and poliglecaprone 25). Sample size was calculated based on a proportion of parastomal hernia of 65% in the control group and 15% in the study group. With an α risk =0.05 and 1- β= 0.8, 28 patients are required, 14 per group. Estimating a drop-out rate of 10%, the final number will be 32 patients. The efficacy will be evaluated clinically at six months and abdominal CT will be performed at 12 months along with another clinical evaluation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of a Lightweight Mesh in the Laparoscopic Prevention of Parastomal Hernia
NCT00908661
Study of a New Laparoscopic Technique for Parastomal Hernia Repair With Mesh
NCT00138957
Use of a Mesh to Prevent Parastomal Hernia
NCT00691860
Prevention of Parastomal Hernias With a Preformed Three-dimensional, Funnel-shaped Mesh
NCT06533839
Role of Prosthetic Mesh in Preventing Parastomal Hernias
NCT01955278
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mesh Group
Patients receiving conventional sigmoid end colostomy plus a preperitoneal lightweight mesh Physiomesh® by laparoscopic procedure
laparoscopic abdominoperineal resection with a lightweight mesh (polypropylene and poliglecaprone 25)
Control Group
Patients receiving conventional sigmoid end colostomy by laparoscopic procedure, without mesh
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laparoscopic abdominoperineal resection with a lightweight mesh (polypropylene and poliglecaprone 25)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Life expectancy above 12 months
Exclusion Criteria
* Carriers of prosthetic meshes in the area of the ostomy
* Patients electively intervened for colorectal surgery (neo de reco) in whom definitive colostomy is indicated after abdominoperineal amputation but not via a laparoscopic approach.
* Cirrhotic patients
* Patients with life expectancy below 12 months due to underlying disease
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Corporacion Parc Tauli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xavier Serra-Aracil
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xavier Serra-Aracil, MD
Role: PRINCIPAL_INVESTIGATOR
Corporacion Sanitaria Universitaria Parc Tauli
Manuel Lopez-Cano, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Vall d'Hebron
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Corporacion Sanitaria Universitaria Parc Tauli
Sabadell, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LAP-APR-2012-028
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.